[HTML][HTML] MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKT

T Shen, W Wang, W Zhou, I Coleman… - The Journal of …, 2021 - Am Soc Clin Investig
Prostate cancer (PCa) is the second leading cause of cancer death in American men.
Androgen receptor (AR) signaling is essential for PCa cell growth/survival and remains a …

[HTML][HTML] MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKT

T Shen, W Wang, W Zhou, I Coleman… - The Journal of …, 2021 - ncbi.nlm.nih.gov
Prostate cancer (PCa) is the second leading cause of cancer death in American men.
Androgen receptor (AR) signaling is essential for PCa cell growth/survival and remains a …

MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKT

T Shen, W Wang, W Zhou… - Journal of …, 2021 - mdanderson.elsevierpure.com
Prostate cancer (PCa) is the second leading cause of cancer death in American men.
Androgen receptor (AR) signaling is essential for PCa cell growth/survival and remains a …

[HTML][HTML] MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKT

T Shen, W Wang, W Zhou, I Coleman… - The Journal of …, 2021 - Am Soc Clin Investig
Prostate cancer (PCa) is the second leading cause of cancer death in American men.
Androgen receptor (AR) signaling is essential for PCa cell growth/survival and remains a …

MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKT.

T Shen, W Wang, W Zhou, I Coleman… - Journal of Clinical …, 2021 - escholarship.org
Prostate cancer (PCa) is the second leading cause of cancer death in American men.
Androgen receptor (AR) signaling is essential for PCa cell growth/survival and remains a …

MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKT.

T Shen, W Wang, W Zhou, I Coleman, Q Cai… - Journal of Clinical …, 2021 - go.gale.com
Prostate cancer (PCa) is the second leading cause of cancer death in American men.
Androgen receptor (AR) signaling is essential for PCa cell growth/survival and remains a …

[PDF][PDF] MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKT

T Shen, W Wang, W Zhou, I Coleman, Q Cai, B Dong… - 2021 - researchgate.net
Prostate cancer (PCa) is the most common cancer after skin cancer and the second leading
cause of cancer death in American men (1). Androgen receptor (AR) signaling is essential …

MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKT

T Shen, W Wang, W Zhou, I Coleman… - The Journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Prostate cancer (PCa) is the second leading cause of cancer death in American men.
Androgen receptor (AR) signaling is essential for PCa cell growth/survival and remains a …

MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKT.

T Shen, W Wang, W Zhou, I Coleman, Q Cai… - The Journal of …, 2021 - europepmc.org
Prostate cancer (PCa) is the second leading cause of cancer death in American men.
Androgen receptor (AR) signaling is essential for PCa cell growth/survival and remains a …

MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKT

T Shen, W Wang, W Zhou, I Coleman… - Journal of Clinical …, 2021 - search.proquest.com
Prostate cancer (PCa) is the second leading cause of cancer death in American men.
Androgen receptor (AR) signaling is essential for PCa cell growth/survival and remains a …